MedPath

Dexchlorpheniramine maleate

Generic Name
Dexchlorpheniramine maleate
Brand Names
Rescon Tablets, Ryclora, Rymed-D
Drug Type
Small Molecule
Chemical Formula
C20H23ClN2O4
CAS Number
2438-32-6
Unique Ingredient Identifier
B10YD955QW

Overview

Dexchlorpheniramine is the S-enantiomer of chlorpheniramine which is a 1st generation anti-histamine. Dexchlorpheniramine has more pharmacological activity than the R and so is more potent than the racemic mixture.

Indication

Dexchlorpheniramine can be used in the treatment of perennial and seasonal allergic rhinitis, vasomotor rhiniti, allergic conjunctivitis due to inhalant allergens and foods, mild uncomplicated allergic skin manifestations of urticaria and angioedema, amelioration of allergic reactions to blood or plasma, and dermographism.

Associated Conditions

  • Allergic Conjunctivitis (AC)
  • Allergic Reaction
  • Allergic Rhinitis (AR)
  • Angioedema
  • Common Cold
  • Dermographism
  • Urticaria
  • Vasomotor Rhinitis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Capellon Pharmaceuticals, LLC
64543-600
ORAL
2 mg in 5 mL
8/21/2023
CARWIN PHARMACEUTICAL ASSOCIATES, LLC
15370-150
ORAL
2 mg in 5 mL
1/8/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
POLARAMINE TAB 2MG
schering-plough canada inc
00028207
Tablet - Oral
2 MG
12/31/1959
POLARAMINE REPETABS 6MG
schering-plough canada inc
00176893
Tablet (Extended-Release) - Oral
6 MG / TAB
12/31/1958

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.